Cargando…
Reduced MHC Class I and II Expression in HPV−Negative vs. HPV−Positive Cervical Cancers
Cervical cancer (CC) is the second most common cancer in women worldwide and the fourth leading cause of cancer-associated death in women. Although human papillomavirus (HPV) infection is associated with nearly all CC, it has recently become clear that HPV−negative (HPV−) CC represents a distinct di...
Autores principales: | Evans, Andris M., Salnikov, Mikhail, Tessier, Tanner M., Mymryk, Joe S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741043/ https://www.ncbi.nlm.nih.gov/pubmed/36497170 http://dx.doi.org/10.3390/cells11233911 |
Ejemplares similares
-
HPV-Positive and -Negative Cervical Cancers Are Immunologically Distinct
por: Evans, Andris M., et al.
Publicado: (2022) -
The HPV Induced Cancer Resource (THInCR): a Suite of Tools for Investigating HPV-Dependent Human Carcinogenesis
por: Salnikov, Mikhail, et al.
Publicado: (2022) -
Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions.
por: Cromme, F. V., et al.
Publicado: (1993) -
HPV negative cervical cancers and primary HPV screening
por: Tjalma, WAA
Publicado: (2018) -
High Level Expression of MHC-II in HPV+ Head and Neck Cancers Suggests that Tumor Epithelial Cells Serve an Important Role as Accessory Antigen Presenting Cells
por: Gameiro, Steven F., et al.
Publicado: (2019)